Inibizione extracellulare dell’oncosoppressore DAB2IP nel tumore prostatico: meccanismi molecolari e implicazioni biologiche” nell’ambito del progetto “Prostate cancer: disentangling the relationships with tumor microenvironment to better model and target tumor progression” finanziato dal Bando PRIN 2017 (rif. 20174PLLYN_004) – CUP J94I19000990001
Our website uses cookies. By continuing we assume your consent to deploy cookies, as detailed in our cookies policy